Clinical Trial Update: Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating low-dose ketamine for perinatal/postpartum depression in women with prenatal depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perinatal Depression
• Postpartum Depression

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Peking University First Hospital | Conditions: Perinatal Depression, Ketamine | Phase 4 | Status: COMPLETED